Evaluate Tocilizumab Alternatives for COVID-19
October 2021
Tocilizumab (Actemra) shortages will continue to raise questions about using an add-on to steroids for COVID-19.
This IL-6 inhibitor is the go-to add-on. But supplies are low...plus hospitals are balancing stock for other indications.
Continue to apply creative solutions. For example, if you have tocilizumab subcutaneous prefilled syringes, consider using them to make IV doses...lab data suggest similar stability. Infuse with a filter.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote